Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2015, Article ID 341064, 5 pages
http://dx.doi.org/10.1155/2015/341064
Case Report

Oxaliplatin-Induced Pulmonary Toxicity in Gastrointestinal Malignancies: Two Case Reports and Review of the Literature

Division of Oncology, Rambam Health Care Campus, 3109601 Haifa, Israel

Received 12 January 2015; Revised 12 April 2015; Accepted 15 April 2015

Academic Editor: David Lindquist

Copyright © 2015 Mor Moskovitz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. De Gramont, A. Figer, M. Seymour et al., “Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer,” Journal of Clinical Oncology, vol. 18, no. 16, pp. 2938–2947, 2000. View at Google Scholar · View at Scopus
  2. T. André, C. Boni, L. Mounedji-Boudiaf et al., “Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer,” The New England Journal of Medicine, vol. 350, no. 23, pp. 2343–2351, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. R. K. Ramanathan, J. W. Clark, N. E. Kemeny et al., “Safety and toxicity analysis of Oxaliplatin combined with fluorouracil or as a single agent in patients with previously treated advanced colorectal cancer,” Journal of Clinical Oncology, vol. 21, no. 15, pp. 2904–2911, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Trisolini, L. Lazzari Agli, D. Tassinari et al., “Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy,” European Respiratory Journal, vol. 18, no. 1, pp. 243–245, 2001. View at Google Scholar · View at Scopus
  5. F. Gagnadoux, C. Roiron, E. Carrie, L. Monnier-Cholley, and B. Lebeau, “Eosinophilic lung disease under chemotherapy with oxaliplatin for colorectal cancer,” American Journal of Clinical Oncology, vol. 25, no. 4, pp. 388–390, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. X. H. Yagüe, E. Soy, B. Q. Merino, J. Puig, M. B. Fabregat, and R. Colomer, “Interstitial pneumonitis after oxaliplatin treatment in colorectal cancer.,” Clinical & Translational Oncology, vol. 7, no. 11, pp. 515–517, 2005. View at Google Scholar · View at Scopus
  7. K. H. Jung, S. Y. Kil, I. K. Choi et al., “Interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX),” International Journal of Tuberculosis and Lung Disease, vol. 10, no. 10, pp. 1181–1182, 2006. View at Google Scholar · View at Scopus
  8. L. M. Pasetto and S. Monfardini, “Is acute dyspnea related to oxaliplatin administration?” World Journal of Gastroenterology, vol. 12, no. 36, pp. 5907–5908, 2006. View at Google Scholar · View at Scopus
  9. A. Ruiz-Casado, M. D. García, and M. A. Racionero, “Pulmonary toxicity of 5-fluoracil and oxaliplatin,” Clinical and Translational Oncology, vol. 8, no. 8, p. 624, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Pena Álvarez, H. J. Suh Oh, A. Sáenz de Miera Rodríguez et al., “Interstitial lung disease associated with oxaliplatin: description of two cases,” Clinical and Translational Oncology, vol. 11, no. 5, pp. 332–333, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Garrido, A. O'Brien, S. González, J. M. Clavero, and E. Orellana, “Cryptogenic organizing pneumonitis during oxaliplatin chemotherapy for colorectal cancer: case report,” Chest, vol. 132, no. 6, pp. 1997–1999, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Mundt, H.-C. Mochmann, H. Ebhardt, M. Zeitz, R. Duchmann, and M. Pauschinger, “Pulmonary fibrosis after chemotherapy with oxaliplatin and 5-fluorouracil for colorectal cancer,” Oncology, vol. 73, no. 3-4, pp. 270–272, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. S. A. Lobera, N. S. Mariñelarena, I. E. Echeberría et al., “Fatal pneumonitis induced by oxaliplatin,” Clinical and Translational Oncology, vol. 10, no. 11, pp. 764–767, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Muneoka, Y. Shirai, M. Sasaki, T. Wakai, J. Sakata, and K. Hatakeyama, “Interstitial pneumonia arising in a patient treated with oxaliplatin, 5-fluorouracil, and, leucovorin (FOLFOX),” International Journal of Clinical Oncology, vol. 14, no. 5, pp. 457–459, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. B. E. Wilcox, J. H. Ryu, and S. Kalra, “Exacerbation of pre-existing interstitial lung disease after oxaliplatin therapy: a report of three cases,” Respiratory Medicine, vol. 102, no. 2, pp. 273–279, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Shah, Z. F. Udwadia, and S. Almel, “Oxaliplatin-induced lung fibrosis,” Indian Journal of Medical and Paediatric Oncology, vol. 30, no. 3, pp. 116–118, 2009. View at Publisher · View at Google Scholar
  17. M. H. Fekrazad, S. Eberhardt, D. Jones, and F.-C. Lee, “Development of bronchiolitis obliterans organizing pneumonia with platinum-based chemotherapy for metastatic rectal cancer,” Clinical Colorectal Cancer, vol. 9, no. 3, pp. 177–178, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. C.-G. Ryu, E.-J. Jung, G. Kim, S. R. Kim, and D.-Y. Hwang, “Oxaliplatin-induced pulmonary fibrosis: two case reports,” Journal of the Korean Society of Coloproctology, vol. 27, no. 5, pp. 266–269, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. J.-I. Lai, W.-S. Wang, Y.-C. Lai, P.-C. Lin, and S.-C. Chang, “Acute interstitial pneumonitis in a patient receiving a FOLFOX-4 regimen plus cetuximab treated with pulse therapy,” International Journal of Clinical Pharmacology and Therapeutics, vol. 48, no. 7, pp. 425–428, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. L. B. Pontes, D. P. D. Armentano, A. Soares, and R. C. Gansl, “Fatal pneumonitis induced by oxaliplatin: description of three cases,” Case Reports in Oncology, vol. 5, no. 1, pp. 104–109, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. E. J. Lee, S. Y. Lee, K. H. In, C. H. Kim, and S. Park, “Organizing pneumonia associated with oxaliplatin-combined chemotherapy: a case report,” Medical Principles and Practice, vol. 21, no. 1, pp. 89–92, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Rubbia-Brandt, V. Audard, P. Sartoretti et al., “Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer,” Annals of Oncology, vol. 15, no. 3, pp. 460–466, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Meadors, J. Floyd, and M. C. Perry, “Pulmonary toxicity of chemotherapy,” Seminars in Oncology, vol. 33, no. 1, pp. 98–105, 2006. View at Publisher · View at Google Scholar · View at Scopus